Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/466
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMooney, T.en
dc.contributor.authorJoseph, P.en
dc.date.accessioned2018-06-16T20:34:19Z-
dc.date.available2018-06-16T20:34:19Z-
dc.date.issued2014en
dc.identifier.citationJanuary 44, (1), 2014, p. 107-108en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/466-
dc.languageenen
dc.relation.ispartofInternal Medicine Journalen
dc.titlePurple toes syndrome following stroke thrombolysis and warfarin therapyen
dc.typeArticleen
dc.identifier.doihttp://dx.doi.org/10.1111/imj.12327en
dc.subject.keywordsagedartery disease/dt [Drug Therapy]en
dc.subject.keywordsartery disease/si [Side Effect]en
dc.subject.keywordsartificial embolismen
dc.subject.keywordsblood clot lysisen
dc.subject.keywordscapillaryen
dc.subject.keywordscase reporten
dc.subject.keywordscerebral artery disease/dt [Drug Therapy]en
dc.subject.keywordscerebrovascular accidenten
dc.subject.keywordscholesterol embolization syndrome/dt [Drug Therapy]en
dc.subject.keywordscholesterol embolization syndrome/si [Side Effect]en
dc.subject.keywordscyanosisen
dc.subject.keywordsdrug withdrawalen
dc.subject.keywordseosinophil counten
dc.subject.keywordsfemaleen
dc.subject.keywordsfeveren
dc.subject.keywordsfooten
dc.subject.keywordsfoot painen
dc.subject.keywordshumanen
dc.subject.keywordsinternational normalized ratioen
dc.subject.keywordsletteren
dc.subject.keywordsleukocyteen
dc.subject.keywordsleukocyte counten
dc.subject.keywordsmiddle cerebral arteryen
dc.subject.keywordsmyalgiaen
dc.subject.keywordspriority journalen
dc.subject.keywordspulse rateen
dc.subject.keywordspurple toes syndrome/dt [Drug Therapy]en
dc.subject.keywordsrashen
dc.subject.keywordsskin discolorationen
dc.subject.keywordsskin necrosis/dt [Drug Therapy]en
dc.subject.keywordsskin necrosis/si [Side Effect]en
dc.subject.keywordsthrombocyte counten
dc.subject.keywordstoeen
dc.subject.keywordsvery elderlyen
dc.subject.keywordsalteplase/dt [Drug Therapy]en
dc.subject.keywordsanticoagulant agent/po [Oral Drug Administration]en
dc.subject.keywordsC reactive protein/ec [Endogenous Compound]en
dc.subject.keywordscreatinine/ec [Endogenous Compound]en
dc.subject.keywordsenoxaparin/dt [Drug Therapy]en
dc.subject.keywordsenoxaparin/sc [Subcutaneous Drug Administration]en
dc.subject.keywordshemoglobin/ec [Endogenous Compound]en
dc.subject.keywordsurea/ec [Endogenous Compound]en
dc.subject.keywordswarfarin/ae [Adverse Drug Reaction]en
dc.subject.keywordswarfarin/dt [Drug Therapy]en
dc.subject.keywordswarfarin/po [Oral Drug Administration]en
dc.relation.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed11&AN=2014063008en
dc.identifier.risid475en
dc.description.pages107-108en
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Sites:Sunshine Coast HHS Publications
Show simple item record

Page view(s)

136
checked on Apr 24, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.